Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms

被引：1
|
作者：
Schoenbeck, Kelly L. [1 ]
Salmasi, Giselle [2 ]
Cerejo, Miguel Carlos [2 ]
Cornett, Patricia A. [2 ]
Damon, Lloyd E. [2 ]
Logan, Aaron C. [2 ]
Olin, Rebecca L. [2 ]
Leavitt, Andrew D. [2 ]
Smith, Catherine C. [2 ]
机构：
[1] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Div Hematol & Blood & Marrow Transplantat, San Francisco, CA 94143 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1165
引用
收藏
页数：4
相关论文
共 50 条
  • [1] BCR-ABL-negative myeloproliferative NeoplasienBCR-ABL negative myeloproliferative neoplasms
    G. Metzgeroth
    E. Lengfelder
    M. Griesshammer
    A. Reiter
    Der Onkologe, 2012, 18 (12): : 1130 - 1138
  • [2] Psychological Symptoms Among Patients With BCR-ABL-Negative Myeloproliferative Neoplasms
    McFarland, Daniel C.
    Polizzi, Heather
    Mascarenhas, John
    Kremyanskaya, Marina
    Holland, Jimmie
    Hoffman, Ronald
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (12): : 1563 - 1570
  • [3] Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms
    J-J Kiladjian
    C Chomienne
    P Fenaux
    Leukemia, 2008, 22 : 1990 - 1998
  • [4] GENETIC ABNORMALITIES IN DIAGNOSTICS OF BCR-ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Kozlovskaya, M.
    Martynkevich, I.
    Petrova, E.
    Martynenko, L.
    Ivanova, M.
    Cybakova, N.
    Gritsaev, S.
    Shuvaev, V.
    Abdulkadyrov, K.
    HAEMATOLOGICA, 2013, 98 : 618 - 618
  • [5] Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms
    Kiladjian, J-J
    Chomienne, C.
    Fenaux, P.
    LEUKEMIA, 2008, 22 (11) : 1990 - 1998
  • [6] High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation
    Wille, Kai
    Sadjadian, Parvis
    Becker, Tatjana
    Kolatzki, Vera
    Horstmann, Anette
    Fuchs, Christiane
    Griesshammer, Martin
    ANNALS OF HEMATOLOGY, 2019, 98 (01) : 93 - 100
  • [7] Biological Rationale and Clinical Use of Interferon in the Classical BCR-ABL-Negative Myeloproliferative Neoplasms
    Stein, Brady L.
    Tiu, Ramon V.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2013, 33 (04): : 145 - 153
  • [8] High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation
    Kai Wille
    Parvis Sadjadian
    Tatjana Becker
    Vera Kolatzki
    Anette Horstmann
    Christiane Fuchs
    Martin Griesshammer
    Annals of Hematology, 2019, 98 : 93 - 100
  • [9] High risk for recurrence of venous thromboembolism in patients with BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation therapy
    Wille, K.
    Sadjadian, P.
    Hostmann, A.
    Kolatzki, V.
    Griesshammer, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 196 - +
  • [10] Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL-Negative Myeloproliferative Neoplasms
    Belliere, Julie
    Colombat, Magali
    Kounde, Clement
    Recher, Christian
    Ribes, David
    Huart, Antoine
    Chauveau, Dominique
    Demas, Veronique
    Luquet, Isabelle
    Beyne-Rauzy, Odile
    Tavitian, Suzanne
    Faguer, Stanislas
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (03): : 737 - 745
12345